Category Archives: Healthcare

T2 Biosystems (TTOO) Initiated with a Buy at Cantor Fitzgerald

T2 Biosystems (NASDAQ: TTOO) received a Buy rating and a $11 price target from Cantor Fitzgerald analyst Jordan Abrams today. The company’s shares closed yesterday at $6.13. Abrams commented: “: We are initiating coverage of T2 Biosystems (TTOO) with an

Wednesday’s Midday Movers: Rosetta Genomics Ltd (ROSG), Rex Energy (REXX), American Green Inc (ERBB), Growlife Inc (PHOT), Hydrogenics Corp (HYGS)

So far Wednesday, September 19, NASDAQ is down -0.91% and the S&P is up 0.31%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Rosetta Genomics Ltd (NASDAQ:ROSG), Rex Energy (NASDAQ:REXX), American Green Inc

Analysts’ Top Healthcare Picks: Verona Pharma Plc (VRNA), Jazz Pharmaceuticals (JAZZ)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Verona Pharma Plc (NASDAQ:VRNA) and Jazz Pharmaceuticals (NASDAQ:JAZZ) with bullish sentiments. Verona Pharma Plc (VRNA) In a report released today, Liana Moussatos

Raymond James Believes Petiq Inc (NASDAQ: PETQ) Still Has Room to Grow

In a report released today, John Ransom from Raymond James maintained a Buy rating on Petiq Inc (NASDAQ: PETQ), with a price target of $45. The company’s shares closed yesterday at $41.77, close to its 52-week high of $43.93. According

Cantor Fitzgerald Believes Neurocrine (NASDAQ: NBIX) Still Has Room to Grow

Cantor Fitzgerald analyst Charles Duncan reiterated a Buy rating on Neurocrine (NASDAQ: NBIX) today and set a price target of $150. The company’s shares closed yesterday at $120.26, close to its 52-week high of $126.98. Duncan said: “We reiterate our

The EVP & GC of BioMarin (NASDAQ: BMRN) is Selling Shares

Today, the EVP & GC of BioMarin (NASDAQ: BMRN), George Eric Davis, sold shares of BMRN for $220.4K. In addition to George Eric Davis, 4 other BMRN executives reported Sell trades in the last month. See today’s analyst top recommended